-
New hope for long COVID blood tests after antibody discovery
pharmatimes
July 14, 2021
A blood test for long COVID could be only six months away after researchers from Imperial College London discovered distinct antibodies in patients with persistent symptoms.
-
Blood test can detect more than 50 types of cancer
pharmatimes
June 28, 2021
Researchers have developed a blood test able detect more than 50 types of cancer that is accurate enough to be used nationally as a multi-cancer screening test in those at higher risk of the disease, including those aged over 50 with no symptoms.
-
Could a DNA Blood Test Spot a Range of Hidden Cancers?
drugs
June 28, 2021
Could a new one-and-done blood test designed to detect as many as 50 different types of cancer become a diagnostic game changer?
-
Blood test can identify COVID-19 patients at high risk of life-threatening complications
europeanpharmaceuticalreview
January 21, 2021
The rapid blood test could be used to identify hospitalised COVID-19 patients who may benefit from investigational treatments and early interventions.
-
Abbott Receives FDA 510(k) Clearance for Rapid Handheld Blood Test for Concussions
americanpharmaceuticalreview
January 15, 2021
Abbott has received 510(k) clearance for the first rapid handheld traumatic brain injury (TBI) blood test, which will help clinicians assess individuals with suspected mild TBIs, including concussions.
-
Abbott receives CE mark for COVID-19 IgG quantitative antibody blood test
europeanpharmaceuticalreview
December 17, 2020
The new quantitative SARS-CoV-2 IgG lab-based serology test developed by Abbott has been given the CE mark.
-
Blood test more predictive of ovarian cancer than ‘previously thought’
pharmatimes
October 30, 2020
An already available blood test can better predict ovarian cancer than was previously thought, according to research published in PLOS Medicine yesterday.
-
Research backs use of liquid biopsy for personalised cancer care
pharmatimes
September 14, 2020
UK research has shown that a blood test is able to identify various mutations in advanced breast cancer and can thus match women to targeted treatment, adding further weight to evidence backing use of liquid biopsies for more personalised cancer care.
-
Researchers develop highly sensitive blood test for cancer
pharmatimes
June 22, 2020
Researchers have developed a new way of analysing cancer patients’ blood for evidence of the disease that could be up to ten times more sensitive than previous methods.
-
Blood Test May Spot Brain Changes of Early Alzheimer's
drugs
August 02, 2019
A simple blood test helped pinpoint the early signs of Alzheimer's in a new study.